Dear students get fully solved assignments Send your semester & Specialization name to our mail id : help.mbaassignments@gmail.com or call us at : 08263069601

1. Dear students get fully solved assignments
Send your semester & Specialization name to our mail id :
help.mbaassignments@gmail.com
or
call us at : 08263069601
AEREN FOUNDATION’S Maharashtra Govt. Reg. No.: F-11724
Case Study Project
Total Marks: 100
SUBJECT - HOSPITAL ADMINISTRATION MANAGEMENT
N. B.: 1)Attempt any Four Questions
2)All questions carries equal marks.
Case Study 1
-- A New Approach to Managing GORD - ALTANA Pharma
ISSUES TO BE DISCUSSED
Q. 1. Discuss the salient features put up in the case.
AN ISO 9001 : 2008 CERTIFIED INTERNATIONAL B-
SCHOOL

2. Answer:Within the framework of its research and development efforts, ALTANA invests in
generatingknowledge.Thisresults,forexample,ininventionsthatALTANA protects with patents as
intellectual property.Butthisdoesnotearnthe company money. On the contrary, research initially
means spending money to generate knowledge.
Unlike adiscoveryoran invention,however,aninnovationismarkedbythe fact thatthe knowledge
generated creates value or benefits for our customers and for ALTANA. With the innovation,
therefore, knowledge is converted into value or benefits.
Q. 2. Evaluate the new approach based on your understanding of the case.
Answer: A newmethodhasbeen developed for diagnosing gastro-oesophageal reflux disease and
assessing treatment progress.
Until now, assessing the progress of treatment for Gastro-Oesaphageal Reflux Disease (GORD) has
reliedprimarilyonanassessment of oesophageal healing. Documenting GORD therapy success is a
difficult task, as mucosal damage does not always correspond with the severity of symptoms.1 In
addition, 70% of all patients with GORD symptoms have endoscopic-negative GORD.
Q. 3. The case indicates two research studies. Give your insights based on these two studies.
Answer:Asa focusedspecialty chemicals company, ALTANA offers its customers highly specialized
technological solutions in niche markets. Due to this business model, innovation is an important
element of the company’s corporate strategy, ensuring that ALTANA will keep growing in the long
term and remain the technology and market leader. ALTANA is therefore a research-intensive
company, which is reflected by the fact that 5 - 6 % of its sales are invested in research and
development – around twice as much as the industry
Case -2
A New Concept in Annuloplasty for Valve Repair: the
Biodegradable Ring - BIORING
ISSUES TO BE DISCUSSED
Q. 1. Bring out the facts as enumerated in the case.

3. Answer:The Kalangos® ring was developed for pediatric annuloplasty to preserve the growth
potential of the child's heart. It is also suitable for adult annuloplasty by extension. This now
commercially available device made of biodegradable polydioxanone induces the growth of
autologous fibrous tissue that reinforces the deficient annulus.
The good functioningof the native,orrepairedvalvedepends on coaptation capacity of its leaflets.
Annuloplasty rings have been used since 1968 to
Q. 2. Analyse the new concept at length in terms of Biodegradable principle.
Answer:Permanent metallic implants are key treatment options in cardiovascular interventions.
However, specific drawbacks limit their more widespread use. These limitations include
thrombogenicity, permanent physical irritation, mismatches in mechanical behaviour between
stented and non-stented vessel areas, long term endothelial dysfunction, inability to adapt to
growth,non-permissive or disadvantageous characteristics for later surgical revascularisation, and
chronic inflammatory local reactions. Degradable implants offer more physiological repair,
reconstitution of local vascular compliance, and a temporary, limited, longitudinal, and radial
straightening effect, including the possibility for growth
Case -3
Bone Substitutes to replace Transplantation?
Points to be addressed
Q. 1. Outline the salient facts of the case.
Answer:Tumours,bone cystsandtraumas,as well asosteomyelitisandosteolysis,cancause massive
bone loss. The primary method used today for filling such defects is autogenic or allogeneic bone
transplantation.Asbothapproachesare associatedwithconsiderable problems there is an ongoing
critical debate as to whether these procedures should still be considered the treatments of choice
Autogenic bone transplantation, for instance, is always associated with another surgery.
Q. 2. Discuss at length on the line of the salient features.
Answer:Properevaluationof the clinical successratesof tissueengineeringtechniques and products
has been hampered by a lack of consistency in the experimental techniques used to induce
periodontal defectsamongdifferentanimal groupsfor preclinical trials, as well as disparities in the
methods used to analyze outcomes obtained by different technologies. The most popular animal

4. models used for the assessment of periodontal regenerative protocols today involve ligature -
induced periodontal defects in nonhuman primates (
Case -4
Eliminating Latent TB
Issues to be Addressed
Q. 1. List out the facts of the case.
Answer:A diagnosisof latenttuberculosis(LTB),alsocalledlatenttuberculosisinfection(LTBI) means
a patient is infected with Mycobacterium tuberculosis, but the patient does not have active
tuberculosis. Active tuberculosis can be contagious while latent tuberculosis is not, and it is
therefore not possible to get TB from someone with latent tuberculosis. The main risk is that
approximately 10% of these patients (5% in the first two years after infection and 0.1% per year
thereafter) will go on to develop active tuberculosis.
Q. 2. Project your perception on the new standard brought out in the testing.
Answer:The global health community has set itself the task of eliminating tuberculosis (TB) as a
public health problem by 2050. Although progress has been made in global TB control, the current
decline in incidence of 2% yr−1 is far from the rate needed to achieve this. If we are to succeed in
thisendeavour,newstrategiestoreduce the reservoirof latentlyinfectedpersons (from which new
cases arise) would be advantageous. However, ascertainment of the extent and risk posed by this
group is poor. The current diagnostics tests (tuberculin skin test and interferon-gamma release
assays) poorly predict who will develop active disease and
Q. 3. Analyse the case example provided.
Answer:Tuberculosis is recognized as the world's leading bacterial cause of death. Yet 95% of
infectionisbelievedtoexistinanasymptomatic'latent'formthatis definednotbythe identification
of bacteria,butby the host immune response inthe formof reactivitytotuberculosisproteinsinthe
tuberculin skin test. It seems likely that clinically defined latent tuberculosis actually represents a
spectrumthat runsfrom eliminationof live bacilli tosubclinical disease:hence,itmightbe unhelpful
to use a single termto describe all these conditions. To support this view, here we focus on recent

5. increased understanding of the heterogeneity in both bacillary physiology and host immune
response that potentially illuminates new therapeutic and
Case-5 --Gamma Knife Surgery – Saving Lives and
Money?
Issues to Addressed
Q. 1. Identify the facts of the case.
Answer:
Q. 2. How would you consider this surgery as an innovative.
Answer:
Q. 3. What exactly is the recourse action the case tried to put forth in terms of saving life and
money?
Answer:
Dear students get fully solved assignments
Send your semester & Specialization name to our mail id :
help.mbaassignments@gmail.com
or
call us at : 08263069601